The global dental market size accounted for USD 39.66 billion in 2024, grew to USD 44.35 billion in 2025 and is expected to be worth around USD 121.22 billion by 2034, registering a CAGR of 11.82% between 2024 and 2034. The North America dental market size is calculated at USD 15.47 billion in 2024 and is expected to grow at a CAGR of 11.95% during the forecast year.
Dental Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID-19 Impact on Dental Market
5.1. COVID-19 Landscape: Dental Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dental Market, by Type, 2024-2034
8.1.1. Dental Consumables
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Dental Equipment
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Dental Market, by End-user, 2024-2034
9.1.1. Solo practices
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. DSO/ group practices
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.2. Market Revenue and Forecast, by End-user (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.1.4.2. Market Revenue and Forecast, by End-user (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.2. Market Revenue and Forecast, by End-user (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.4.2. Market Revenue and Forecast, by End-user (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.5.2. Market Revenue and Forecast, by End-user (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.2.6.2. Market Revenue and Forecast, by End-user (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.4.2. Market Revenue and Forecast, by End-user (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.5.2. Market Revenue and Forecast, by End-user (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.3.6.2. Market Revenue and Forecast, by End-user (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.2. Market Revenue and Forecast, by End-user (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.4.2. Market Revenue and Forecast, by End-user (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.5.2. Market Revenue and Forecast, by End-user (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
10.4.6.2. Market Revenue and Forecast, by End-user (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.2. Market Revenue and Forecast, by End-user (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.3.2. Market Revenue and Forecast, by End-user (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
10.5.4.2. Market Revenue and Forecast, by End-user (2021-2034)
11.1. 3M (U.S.)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Institut Straumann AG (Switzerland)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Henry Schein, Inc. (U.S.)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Angelalign Technology Inc. (China)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. SHOFU INC. (Japan)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Dentsply Sirona (U.S.)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Align Technology, Inc. (U.S.)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Zimmer Biomet (U.S.)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Coltene (Switzerland)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. BIOLASE, Inc. (U.S.)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client